Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 102 participants.
Also called NCT03728985
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT03728985
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03728985. Non-randomized; no masking; primary purpose treatment. Start 2019-06-17 (actual); primary completion 2023-01-04 (actual). Results posted on 2024-08-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
- Acronym
- TAMBE
- Condition
- Thoracoabdominal Aortic Aneurysm
- Intervention (Device)
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct03728985- Content hash
289268dbf42c3ec1cf86c48e960c4a0da3e38143e2b9042498985ab74ceb6547